Monitor future quarters for InSet Go adoption metrics and revenue contribution. The limited user release precedes full commercial launch, so near-term financial impact is minimal.
Price Chart
Executive Summary
Shoulder Innovations announced the limited user release of its next-generation InSet Go glenoid implant for anatomic shoulder arthroplasty, following the first successful surgical case. This is a product launch milestone for a commercial-stage medtech company, but no financial data or revenue guidance was provided in the filing.
Key Facts
- Limited user release of InSet Go, a next-generation glenoid implant, initiated on October 8, 2026.
- First surgical case performed by Robert Gillespie, MD, at University Hospitals Cleveland Medical Center.
- InSet Go builds on the existing InSet glenoid technology, designed to reduce implant loosening and simplify surgical technique.
- Full commercial introduction expected over the coming quarters.
- No financial metrics, revenue figures, or guidance were disclosed.
Financial Impact
No financial figures disclosed; product launch milestone without revenue or cost data.
Risk Factors
- Competitive response from established shoulder arthroplasty implant makers.
- Surgeon adoption may be slower than anticipated.
- No pricing or revenue guidance provided to assess commercial traction.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001699350-26-000058 |
| Exhibit: ex-991pressrelease10x8x2026.htm | 0001699350-26-000058 |
| Document: 0001699350-26-000058-index-headers.html | 0001699350-26-000058 |
| Document: 0001699350-26-000058-index.html | 0001699350-26-000058 |
| Document: 0001699350-26-000058.txt | 0001699350-26-000058 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $18.09 | awaiting T+60 | — | $19.38 (+7.13%) |
Oct 8, 2026 18d ago | 8-K | $17.89 | awaiting T+60 | — | $19.38 (+8.33%) |
Aug 24, 2026 9w ago | Insider Cluster | $22.32 | awaiting T+60 | — | $19.38 (−13.17%) |
Aug 14, 2026 10w ago | EFFECT | $20.73 | awaiting T+60 | — | $19.38 (−6.51%) |
Aug 10, 2026 11w ago | 8-K | $20.75 | awaiting T+60 | — | $19.38 (−6.60%) |
Jul 29, 2026 12w ago | 144 | $23.72 $19.75 | ▲ +16.74% | ▲ +21.47% | $19.38 (+18.30%) |
Jun 29, 2026 17w ago | 8-K | $21.09 $17.61 | ▼ −16.50% | ▼ −20.89% | $19.38 (−8.11%) |
May 13, 2026 23w ago | 8-K | $15.59 $20.75 | ▲ +33.10% | ▲ +29.51% | $19.38 (+24.31%) |
Apr 29, 2026 25w ago | DEFA14A | $12.28 $20.41 | ▲ +66.21% | ▲ +62.09% | $19.38 (+57.82%) |
Apr 27, 2026 26w ago | 8-K | $13.53 $20.31 | ▲ +50.11% | ▲ +45.33% | $19.38 (+43.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers